Valuation: Center Laboratories, Inc.

Market Cap 29.71B 927M 812M 748M 694M 1.32B 88.42B 1.34B 8.95B 3.48B 43.4B 3.48B 3.4B 150B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 33.75B 1.05B 922M 849M 789M 1.5B 100B 1.52B 10.17B 3.96B 49.31B 3.95B 3.87B 171B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day+0.38%
1 week+4.60%
Current month+4.33%
1 month+2.58%
3 months-4.56%
6 months-0.87%
Current year-4.33%
1 week 37.9
Extreme 37.9
40.55
1 month 36.8
Extreme 36.8
40.55
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 03/08/1998
Director of Finance/CFO - 08/12/2022
Chief Tech/Sci/R&D Officer - 01/07/1983
Director TitleAgeSince
Chairman - 30/11/2022
Director/Board Member 61 14/06/2010
Director/Board Member - 14/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%+4.60%+13.48%-19.50% 927M
-1.14%-2.43%+53.72%+159.07% 1,070B
-1.41%+0.32%+66.23%+60.48% 624B
-2.42%+0.18%+34.59%+85.62% 450B
-0.72%+0.53%+31.00%+25.82% 328B
+1.45%+1.12%+39.54%+41.03% 292B
+0.78%-0.63%+28.86%+48.13% 284B
+2.39%+4.32%-25.61%-38.88% 217B
-2.06%+1.63%+22.87%+64.34% 198B
-1.26%+2.60%+15.98%+70.00% 161B
Average +0.44%+1.40%+28.07%+49.61% 362.53B
Weighted average by Cap. +0.78%+0.77%+40.23%+81.70%

Financials

2024 2025
Net sales 1.62B 50.48M 44.21M 40.72M 37.79M 71.77M 4.81B 72.74M 487M 190M 2.36B 190M 185M 8.19B 1.52B 47.3M 41.43M 38.16M 35.42M 67.26M 4.51B 68.17M 457M 178M 2.21B 178M 174M 7.68B
Net income -1.1B -34.43M -30.16M -27.78M -25.78M -48.96M -3.28B -49.62M -332M -129M -1.61B -129M -126M -5.59B 9.32B 291M 255M 235M 218M 414M 27.75B 419M 2.81B 1.09B 13.62B 1.09B 1.07B 47.22B
Net Debt 4.48B 140M 122M 113M 105M 199M 13.33B 201M 1.35B 525M 6.54B 525M 513M 22.69B 4.04B 126M 110M 102M 94.41M 179M 12.03B 182M 1.22B 474M 5.9B 474M 463M 20.47B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
06/07/26 NT$39.80 +0.38% 4,071,591
03/07/26 NT$39.65 +3.26% 8,219,167
02/07/26 NT$38.40 +0.79% 3,044,141
01/07/26 NT$38.10 -0.13% 1,346,883
30/06/26 NT$38.15 +0.26% 1,735,048
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. 4123 Stock